BioCurity Announces Presentation at ACRO Summit 2022
10 Mar 2022 //
BUSINESSWIRE
BioCurity Pharma Expands Patent Portfolio Successes for Supportive Cancer Drugs
10 Mar 2022 //
BUSINESSWIRE
BioCurity Announces Presentation of Data on Cerium Oxide Nanoparticles
12 Jan 2022 //
BUSINESSWIRE